# ImmunityBio, Inc.: Form 8-K, filed Feb 10, 2021

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2021-02-10
- Accepted by EDGAR: Feb 10, 2021, 16:38 ET
- Period: 2021-02-05
- Accession: 0001193125-21-036358
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312521036358/d116316d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312521036358/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312521036358/d116316d8k.htm

Filed Feb 10, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-036358. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
